FDA Approvals

Date Posted
Article Title
5/6/2011
Afinitor Approved for Rare Pancreatic Cancer

Extended survival in clinical studies

5/2/2011
Tradjenta Approved for Type 2 Diabetes

The disease's most common form

4/29/2011
Zytiga Approved for Advanced Prostate Cancer

FDA: Improved patient survival shown in clinical testing

4/25/2011
4/14/2011
Device Approved to Treat Brain Aneurysm

A weakened bulge in an artery

4/13/2011
New RX for Large Brain Aneurysm

Treatment for bulge in an artery wall

4/11/2011
1st U.S. Test to Diagnose Dengue Fever Approved

Illness more common in Latin America, Caribbean and Asia

4/8/2011
FDA OKs Rapid Test to Spot Dangerous Intestinal Infection

C. difficile is commonly acquired in hospitals

4/7/2011
Horizant Approved to Treat Restless Legs Syndrome

Possible side effects include drowsiness and dizziness

4/7/2011
Vandetanib Approved for a Rare Thyroid Cancer

Designed to extend survival in patients with late-stage disease

4/4/2011
Nerve Stimulation Device Approved to Restore Bowel Control

For people with chronic fecal incontinence

3/29/2011
Just-Approved Defibrillators Limit Unnecessary Shocks

Medtronic devices said to recognize irregular heartbeat that's life-threatening

3/25/2011
Drug Approved for Late-Stage Melanoma

Yervoy fights deadly form of skin cancer, agency says

3/24/2011
U.S. Shingles Vaccine Approval Expanded

To include people in their 50s

3/15/2011
Gadavist Approved to Enhance Nervous System Imaging

A contrast agent for certain MRIs

3/11/2011
Device Approved to Continue Blood Flow During Brain Surgery

Among patients at greater risk of stroke

3/10/2011
Benlysta Approved for Lupus

Last-approved lupus drug sanctioned 56 years ago

3/1/2011
Roflumilast Approved for Form of COPD

Drug aimed at treating lung disease characterized by chronic bronchitis

2/28/2011
Edarbi Approved for High Blood Pressure

But shouldn't be taken by pregnant women

2/18/2011